|
1 |
Anatomy, biology, physiology, pharmacology (fundamental research) |
|
1.1 |
Addiction |
|
1.2 |
Anticonvulsants |
|
1.3 |
Antidepressants |
|
1.4 |
Brainstem, Thalamus and Cortex |
|
1.5 |
Cannabinoids |
|
1.6 |
Central Sensitization |
|
1.7 |
Channels |
|
1.8 |
Clinical Neurophysiology |
|
1.9 |
Endogenous Pain Modulation |
|
1.10 |
Functional Brain Imaging |
|
1.11 |
Gender Differences |
|
1.12 |
Gene Expression |
|
1.13 |
Hyperalgesia/Allodynia |
|
1.14 |
Local anaesthetics |
|
1.15 |
Neuronal Excitability |
|
1.16 |
Neuronal Inhibition |
|
1.17 |
NSAIDs, COXIBs Acetaminophen |
|
1.18 |
Opioids |
|
1.19 |
Pain Pathways |
|
1.20 |
Peptides |
|
1.21 |
Primary Afferents |
|
1.22 |
Psychophysics and experimental |
|
1.23 |
Receptors |
|
1.24 |
Signal Transduction |
|
1.25 |
Sympathetic Nervous System/Pain |
|
1.26 |
Tolerance |
|
1.27 |
Other |
|
2 |
Animal, human models |
|
2.1 |
Animal Models of Acute Pain |
|
2.2 |
Animal Models of Chronic Pain |
|
2.3 |
Animal Models of Neuropathic Pain |
|
2.4 |
Human Models of Acute Pain |
|
2.5 |
Human Models of Chronic Pain |
|
2.6 |
Human Models of Neuropathic Pain |
|
3 |
Diseases |
|
3.1 |
Amputation Pain |
|
3.2 |
Arthritis |
|
3.3 |
Back Pain |
|
3.4 |
Cancer Pain |
|
3.5 |
Central Pain |
|
3.6 |
Complex Regional Pain Syndrome |
|
3.7 |
End of life |
|
3.8 |
Fibromyalgia |
|
3.9 |
Headache |
|
3.10 |
HIV/AIDS Pain |
|
3.11 |
Inflammation |
|
3.12 |
Joint Pain |
|
3.13 |
Migraine |
|
3.14 |
Myofascial Pain and Muscle Pain |
|
3.15 |
Neuropathic Pain |
|
3.16 |
Obstetric Pain |
|
3.17 |
Orofacial Pain |
|
3.18 |
Pain and Dementia |
|
3.19 |
Pain and Depression |
|
3.20 |
Pain and Suicide |
|
3.21 |
Pain in Children |
|
3.22 |
Pain in the Elderly |
|
3.23 |
Pain in Men |
|
3.24 |
Pain in Women |
|
3.25 |
Perioperative Pain |
|
3.26 |
Procedural Pain |
|
3.27 |
Urogenital Pain |
|
3.28 |
Visceral Pain |
|
4 |
Treatment approaches (conservative) |
|
4.1 |
Acute Pain – Opioids |
|
4.2 |
Acute Pain – NSAIDs |
|
4.3 |
Anticonvulsants |
|
4.4 |
Antidepressants |
|
4.5 |
Cancer Pain – Opioids |
|
4.6 |
Cancer Pain – Other |
|
4.7 |
Cannabinoids |
|
4.8 |
Novel Therapeutic Agents |
|
4.9 |
NSAIDs, COX2 Inhibitors and Acetaminophen |
|
4.10 |
Opioids – Clinical Pharmacology |
|
4.11 |
Opioids in Non-Cancer Pain |
|
4.12 |
Palliative Care |
|
4.13 |
Placebo |
|
4.14 |
Preemptive Analgesia |
|
4.15 |
Topical Analgesics |
|
5 |
Treatment approaches (invasive) |
|
5.1 |
Brain, Spinal, and Peripheral Stimulation |
|
5.2 |
Nerve Blocks, Indwelling Catheters |
|
5.3 |
Neural Stimulation – DBS/DCS/TENS |
|
5.4 |
Radiofrequency Blocks |
|
5.5 |
Spinal Analgesia |
|
5.6 |
Sympathetic Blocks |
|
6 |
Treatment approaches (other) |
|
6.1 |
Acupuncture |
|
6.2 |
Complementary/Alternative Medicine |
|
6.3 |
Exercise |
|
6.4 |
Open and Hidden Therapy |
|
6.5 |
Physiotherapy |
|
6.6 |
Rehabilitation Medicine |
|
6.7 |
Other |
|
7 |
Treatment approaches (psychosocial and cognitive) |
|
7.1 |
Cognitive Approaches |
|
7.2 |
Behavioural Approaches |
|
7.3 |
Coping Strategies |
|
7.4 |
Other |
|
8 |
Multi/interdisciplinary treatment approaches |
|
9 |
Organisation, assessment, measurement |
|
9.1 |
Acute Pain Services |
|
9.2 |
Assessment |
|
9.3 |
Assessment in Children |
|
9.4 |
Assessment in Elderly |
|
9.5 |
Assessment in Mentally Impaired |
|
9.6 |
Clinical Outcomes Measurement |
|
9.7 |
Documentation |
|
9.8 |
Meta-analysis |
|
9.9 |
Multidisciplinary Units |
|
9.10 |
Pain Clinics |
|
9.11 |
Pain Services |
|
9.12 |
Systematic Reviews |
|
9.13 |
Epidemiology of Pain |
|
9.14 |
Psychological Assessment |
|
9.15 |
Functional Assessment |
|
9.16 |
Palliative Teams |
|
10 |
Ethics, education, law |
|
10.1 |
Education/Professional |
|
10.2 |
Education / Lay |
|
10.3 |
Ethics – Animal Research |
|
10.4 |
Ethics - Clinical Practice |
|
10.5 |
History of Pain |
|
10.6 |
Public Perception |
|
10.7 |
Right to Pain Treatment |